Skip to the page

Data / Medical devices / Serbia / Visaris D.O.O.

Visaris D.O.O.: FDA-registered device maker in Zemun Beograd, Serbia, 2 510(k) clearances

Visaris D.O.O. is registered with the FDA (registration 3012569470) in Zemun Beograd, Serbia. It lists 5 device types. The FDA files 2 510(k) clearances under its listings, the newest dated March 30, 2016. 1 recall event names it as the recalling firm. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3012569470
Address
Batajnicki drum 10. deo 1B, Zemun Beograd, Serbia, 11080
Owner or operator
Visaris d.o.o. (10051372)
Roles
Manufacturer, Repackager or relabeler
First device listed
March 8, 2016
Registered through
2027
Brand names listed
Avanse, Avanse DR, LuminX DR Retrofit, LuminX FMTS, LuminX Overhead, LuminX Overhead Auto, LuminX Straight Arm, LuminX U-Arm Auto and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
March 30, 2016K160620Visaris Vision® (Vision C, Vision U. Vision V, Vision X)KPRSubstantially EquivalentVisaris D.O.O. Belgradeaccessdata.fda.gov
June 8, 2015K150725Visaris AvanseKPRSubstantially EquivalentVisaris D.O.O. Belgradeaccessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
April 5, 201879848Class IITerminatedVisaris Vision/Auto, ddRAura OTC APS, Diagnostic X-Ray System, Version 2.2 The Vision systems are intended for use in all areas of diagnostic radiography imaging and specifically at secondary and tertiary levels of medicA failure of the tube arm suspension is possible while the tube arm height is being adjusted. During tube height adjustment there is a small probability of failure of both the primary and redundant holding mechanisms, causing uncontrollable descent of the tube arm and a potential risk of injury to the patient.accessdata.fda.gov

Compare with other makers

Updated March 30, 2016. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.